808793-55-7

Basic information

• Product Name: 3-benzyl-3,4-dihydro-4-oxo-6-acetyloxy-7-methoxy-quinazoline
• Synonyms: 3-benzyl-3,4-dihydro-4-oxo-6-acetyloxy-7-methoxy-quinazoline
• CAS NO: 808793-55-7
• Molecular Weight: 324.336
• Mol File: 808793-55-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-benzyl-3,4-dihydro-4-oxo-6-acetyloxy-7-methoxy-quinazoline(CAS DataBase Reference)
• NIST Chemistry Reference: 3-benzyl-3,4-dihydro-4-oxo-6-acetyloxy-7-methoxy-quinazoline(808793-55-7)
• EPA Substance Registry System: 3-benzyl-3,4-dihydro-4-oxo-6-acetyloxy-7-methoxy-quinazoline(808793-55-7)

Safety Data

• Hazardous Substances Data: 808793-55-7(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 179688-53-0 6-acetoxy-7-methoxy-3,4-dihydroquinazolin-4-one 

Downstream Products

• 1046452-35-0 3-benzyl-3,4-dihydro-4-oxo-6-(1,4-dioxa-spiro[4,5]decan-8-yl-oxy)-7-methoxy-quinazoline 
• 1046137-42-1 4-[(3-chloro-2-fluoro-phenyl)amino]-6-(4-oxo-cyclohexyloxy)-7-methoxy-quinazoline 
• 808793-56-8 3-benzyl-6-hydroxy-7-methoxy-3H-quinazolin-4-one 
• 1024015-16-4 4-[(3-chloro-2-fluoro-phenyl)amino]-6-[cis-4-(N-morpholinocarbonyl-N-methyl-amino)-cyclohexyl-oxy]-7-methoxy-quinazoline 
• 941598-34-1 3-benzyl-3,4-dihydro-4-oxo-6-[cis-4-(N-morpholinocarbonyl-N-methyl-amino)-cyclohexyl-oxy]-7-methoxy-quinazoline 
• 941598-41-0 3,4-dihydro-4-oxo-6-[cis-4-(N-morpholinocarbonyl-N-methyl-amino)-cyclohexyl-oxy]-7-methoxy-quinazoline 
• 941598-33-0 3-benzyl-3,4-dihydro-4-oxo-6-{cis-4-[N-(tert-butyloxycarbonyl)-N-methyl-amino]-cyclohexyl-oxy}-7-methoxy-quinazoline 

Relevant articles and documents

CYCLOHEXYLOXY-SUBSTITUTED HETEROCYCLICS, MEDICINES CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

The present invention relates to cyclohexyloxy-substituted heterocycles of general formula (I) the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organi

BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF

The present invention relates to bicyclic heterocycles of general formula wherein Ra, Rb and Rc are defined as in claim 1, their tautomers, their stereoisomers, their mixtures and their salts, in particular their physiolog

BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, THE USE THEREOF AND METHOD FOR PREPARING THE SAME

The invention relates to the bicyclic heterocycles of general formula (I), wherein R, R, R, R, X and n are defined as in claim 1, to their tautomers, stereoisomers, mixtures and salts thereof, especially the physiologically acceptable salts thereof with inorganic or organic acids. The inventive compounds have valuable pharmacological properties, especially they inhibit tyrosinkinase-mediated signal transduction. The invention also relates to the use of said compounds for treating diseases, especially tumor diseases and benign prostatic hyperplasia (BPH), diseases of the lung and respiratory tracts, and to the production of these compounds.